Oncolytics Biotech Inc (ONCY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2023 | 12-2022 | 12-2021 | 12-2020 | 12-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -20,559 | -19,103 | -20,988 | -16,800 | -24,961 |
| Depreciation Amortization | 299 | 302 | 361 | 333 | 366 |
| Other Working Capital | 1,308 | 301 | -725 | 157 | -1,353 |
| Other Operating Activity | -2,122 | 536 | 3,452 | -164 | 10,948 |
| Operating Cash Flow | $-21,074 | $-17,965 | $-17,900 | $-16,474 | $-15,001 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 14,986 | -15,652 | N/A | N/A | N/A |
| PPE Investments | -6 | -42 | -228 | -22 | -8 |
| Investing Cash Flow | $14,981 | $-15,694 | $-228 | $-22 | $-8 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 15,823 | N/A | 184 | 1,266 | 10,047 |
| Other Financing Activity | 7,878 | 9,388 | 26,159 | 28,425 | 5,791 |
| Financing Cash Flow | $23,701 | $9,388 | $26,343 | $29,691 | $15,837 |
| Exchange Rate Effect | -387 | 1,505 | -202 | -451 | -490 |
| Beginning Cash Position | 8,642 | 31,739 | 24,910 | 10,562 | 10,324 |
| End Cash Position | 25,863 | 8,974 | 32,923 | 23,305 | 10,662 |
| Net Cash Flow | $17,221 | $-22,765 | $8,013 | $12,744 | $338 |
| Free Cash Flow | |||||
| Operating Cash Flow | -21,074 | -17,965 | -17,900 | -16,474 | -15,001 |
| Capital Expenditure | -6 | -42 | -228 | -22 | -8 |
| Free Cash Flow | -21,080 | -18,007 | -18,128 | -16,496 | -15,010 |